Global Health Alliance

Global Health Alliance UKs Up-To-Date short, focused & certified courses for Nurses,Doctors,Paramedics,Cardiac Physiologists & General Public. By : UK Universities & Hospitals.

Join us for the Post ACC 2026 Spotlight Summit featuring esteemed faculty Dr. Rajay Narain (MRCP, UK) and Prof. Derek Co...
10/04/2026

Join us for the Post ACC 2026 Spotlight Summit featuring esteemed faculty Dr. Rajay Narain (MRCP, UK) and Prof. Derek Connolly (FRCP).

Gain valuable insights into the latest research, evolving clinical guidelines, and innovative care pathways in cardiovascular health, with a focus on reducing cardiovascular burden through lipid excellence.

📅 15 April 2026
⏰ 6–7 PM (UK Time)
🌐 Online | Earn 2 CME Credit Points

Don’t miss this opportunity to learn from leading experts in cardiology.

On this World Health Day, we’re reminded that health is not a privilege it’s a right that belongs to every individual, ...
07/04/2026

On this World Health Day, we’re reminded that health is not a privilege it’s a right that belongs to every individual, everywhere. 🌍❤️

In a world where diseases don’t respect borders, our response must be united, inclusive, and compassionate. True global health means reaching the unreached, supporting communities, and ensuring that even the most vulnerable have access to care, protection, and awareness.

Let’s continue to stand together, act together, and care together for a better, healthier tomorrow.

At American College of Cardiology 2026, the SMART-DECISION Trial provides compelling evidence that stopping beta-blocker...
03/04/2026

At American College of Cardiology 2026, the SMART-DECISION Trial provides compelling evidence that stopping beta-blockers one year after MI may be a safe and effective approach in carefully selected patients.

With no significant difference in outcomes such as mortality, recurrent MI, or heart failure hospitalization, this study marks a pivotal step toward personalized cardiology care and optimized treatment pathways.

Advancing precision in interventional cardiology ❤️‍🩺Insights from the IVUS-CHIP Trial highlight that while IVUS-guided ...
02/04/2026

Advancing precision in interventional cardiology ❤️‍🩺

Insights from the IVUS-CHIP Trial highlight that while IVUS-guided PCI improves stent optimization, it may not significantly reduce target vessel failure compared to angiography-guided PCI alone.

A valuable step toward refining strategies for managing complex high-risk patients and improving cardiovascular outcomes globally.

EZ-PAVE Trial 🧬Lower targets. Better outcomes.The EZ-PAVE trial reinforces that pushing LDL-C targets below 55 mg/dL sig...
29/03/2026

EZ-PAVE Trial 🧬

Lower targets. Better outcomes.

The EZ-PAVE trial reinforces that pushing LDL-C targets below 55 mg/dL significantly reduces cardiovascular risk compared to conventional goals.

Precision prevention is the future of cardiology.

Presented at the American College of Cardiology where science meets impact.

CHAMPION-AF Trial ❤️Device vs drugs:closing the gap.The CHAMPION-AF trial highlights that left atrial appendage closure ...
29/03/2026

CHAMPION-AF Trial ❤️

Device vs drugs:closing the gap.

The CHAMPION-AF trial highlights that left atrial appendage closure is non-inferior to NOAC therapy and may reduce bleeding risks.

A shift in how we approach stroke prevention in AFib patients.

Another step forward from the American College of Cardiology.

KARDINAL Trial 💊New therapy, nuanced outcomes.KARDINAL shows promise in reducing angiotensinogen levels with monthly the...
29/03/2026

KARDINAL Trial 💊

New therapy, nuanced outcomes.

KARDINAL shows promise in reducing angiotensinogen levels with monthly therapy but without significant additional BP reduction.

A reminder: biomarkers don’t always translate into clinical endpoints.

Evidence from the American College of Cardiology continues to refine how we treat hypertension.

Rethinking timing in acute cardiac care.The STEMI-DTU trial challenges a key assumption: mechanical LV unloading with de...
29/03/2026

Rethinking timing in acute cardiac care.

The STEMI-DTU trial challenges a key assumption: mechanical LV unloading with delayed PCI did not reduce infarct size compared to immediate intervention.

Sometimes, faster is still better.

Insights like these from the American College of Cardiology remind us why evidence always leads the way.

Excited to share that Global Health Alliance (GHA UK) is attending the prestigious ACC 75th Annual Scientific Session & ...
28/03/2026

Excited to share that Global Health Alliance (GHA UK) is attending the prestigious ACC 75th Annual Scientific Session & Expo in New Orleans! 🇺🇸

Looking forward to connecting with global leaders in cardiology and fostering meaningful collaborations. ❤️

✨ Our Focus:

🔹 Advancing global collaboration in cardiovascular care
🔹 Engaging with top medical experts & institutions
🔹 Building impactful international partnerships
🔹 Promoting medical education & healthcare upskilling

On World Tuberculosis Day, we reaffirm our commitment to advancing awareness, early detection, and access to quality car...
24/03/2026

On World Tuberculosis Day, we reaffirm our commitment to advancing awareness, early detection, and access to quality care.

Together, we can build a TB-free future.

Advancing healthcare through knowledge, collaboration, and innovation. 🌍✨Global Health Alliance UK is dedicated to empow...
23/03/2026

Advancing healthcare through knowledge, collaboration, and innovation. 🌍✨

Global Health Alliance UK is dedicated to empowering healthcare professionals with:

• Medical Affairs expertise
• World-class Medical Education
• High-impact Conferences & Events
• Healthcare Skilling Courses

Shaping the future of global healthcare one professional at a time. 💙

ACC 2026 Dyslipidemia Updates — Key Takeaways:• Enhanced risk prediction with PREVENT-ASCVD, capturing both 10-year and ...
21/03/2026

ACC 2026 Dyslipidemia Updates — Key Takeaways:

• Enhanced risk prediction with PREVENT-ASCVD, capturing both 10-year and lifetime (30-year) cardiovascular risk

• CAC scoring emerging as a key tool to refine risk stratification and personalize treatment decisions

• More aggressive LDL-C targets (

Address

London

Website

Alerts

Be the first to know and let us send you an email when Global Health Alliance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Global Health Alliance:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category